SAN DIEGO–(BUSINESS WIRE)–CorTechs Labs Inc. announced today that it has officially entered the second phase of its project titled, Diagnosis of Alzheimer’s disease and prediction of clinical progression using an automated PET image analysis tool. This project, funded by a $1.15 million, multi-year grant from the National Institutes of Health (NIH), was awarded to CorTechs Labs in December of 2018. The grant was awarded to reshape how Alzheimer’s disease is diagnosed. During the first phase, CorTechs Labs worked on delivery methods using an automated PET image analysis tool to determine a patient’s risk of developing Alzheimer’s and to monitor disease

This content is restricted to site members. If you are an existing user, please log in. New users may register too.